Viking Therapeutics

This is a discussion on Viking Therapeutics within the Stocks forums, part of the Markets category; Viking Therapeutics (VKTX) stock shot up over 100%, despite the fact that ValueEngine downgraded the company from Strong Buy to ...

Reply
 
LinkBack Thread Tools Search this Thread
Old Jun 1, 2018, 9:25am   #1
Joined Mar 2018
Viking Therapeutics

Viking Therapeutics (VKTX) stock shot up over 100%, despite the fact that ValueEngine downgraded the company from Strong Buy to Buy.

The stock moved up in response to Madrigal Pharmaceuticals' announcement of successful 36-week results from a Phase 2 study of NonAlcoholic SteatoHepatitis (NASH) candidate MGL-3196, a thyroid hormone receptor-beta agonist. Viking's NASH candidate, Phase 2-stage VK2809, has the same mechanism of action.
KyleLennon is offline   Reply With Quote
Reply

Thread Tools Search this Thread
Search this Thread:

Advanced Search

Similar Threads
Thread Thread Starter Forum Replies Last Post
Cara Therapeutics KyleLennon Stocks 0 May 26, 2018 2:34pm
Sarepta Therapeutics is Crazy!! KyleLennon Stocks 0 May 20, 2018 3:52pm
PPL Therapeutics traderx Stocks 6 Feb 28, 2001 12:53pm

Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)